Biotech News
Stem Cell-Derived Therapy Shows Early Promise for Resistant Liver Cancer
An innovative new stem cell-derived therapy could be used to better target and treat the most common form of liver cancer.
FDA Approves First One-time Cell Therapy for a Solid Tumor
Friday, the FDA granted approval to Iovance Biotherapeutics’ lifileucel as the first one-time cell therapy for a solid tumor and the first tumor-infiltrating lymphocytes (TIL) therapy. Amtagvi, as lifileucel will be known commercially, was approved ...
A team of researchers has created 3D bioprinted liver models
Metabolic dysfunction–associated steatohepatitis (MASH), previously referred to as nonalcoholic steatohepatitis, is an inflammatory condition characterized by the accumulation of fat in the liver, which can lead to cirrhosis and liver failure. With no cure for ...
New technique may aid Parkinson’s cell therapies’ efficiency
Scientists have developed a more efficient method for using stem cells to create new dopaminergic neurons, the dopamine-making nerve cells whose death and dysfunction causes Parkinson’s disease. The technique was detailed in Nature Communications, in the study, ...
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
FDA approves Casgevy and Lyfgenia, the first gene therapy to treat Sickle cell disease